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leads to severe disruption of major skeletal derivatives of anterior 
NCCs. We show that, within the NCC genetic network, hmga2 acts downstream 
of msx1, and is required for msx1, pax3 and snail2 activities, thus 
participating at different levels of the network. Because of hmga2 early 
effects in NCC specification, the subsequent epithelial-mesenchymal 
transition (EMT) and migration of NCCs towards the branchial pouches are 
also compromised. Strictly paralleling results on embryos, interfering 
with Hmga2 in a breast cancer cell model for EMT leads to molecular 
effects largely consistent with those observed on NCCs. These data 
indicate that Hmga2 is recruited in key molecular events that are shared 
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Dear Editor, 
 
please find our revision of the paper DBIO-15-265. 
 
We were happy to know that all the Reviewers find merits in the paper. 
 
We have performed additional experiments suggested by the reviewers and integrated 
and discussed new results in the present version. We think that the paper has been 
improved by these modifications and we hope that this new version can be accepted 
for publication. 
 
We have addressed some of the issues raised by Referees as follows: 
 
 
 
Response to Reviewer 1 
 
1) The reviewer correctly makes the point that the “MO knock down phenotype is an 
early phenotype and therefore could both directly or indirectly affect many facets of 
*Response to Reviews
neural crest cell behavior. If neural crest induction is perturbed a lot of processes 
could be disrupted such as EMT and neural crest morphogenesis.” 
 
RESPONSE: We agree with the view that impairment of EMT and migration could 
be a consequence of earlier effects on specification. However, already in the previous 
version of the manuscript, we did not definitely conclude that we demonstrated that 
hmga2 is directly involved in the phase of EMT and migration of NCCs, but, rather, 
that hmga2 depletion impaired specification of NCCs and, as a consequence, the 
following EMT and migration phase. This is stated several times in the Manuscript 
(Abstract: “Because of hmga2 early effects in NCC specification, the subsequent 
epithelial-mesenchymal transition (EMT) and migration of NCCs towards the 
branchial pouches are compromised”); in the Discussion we then say that “we did not 
uncouple the hmga2 knockdown early effects on NCC specification from possible 
later effects on EMT/migration”. In fact, after discussing our results in EMT cell 
culture models we conclude that “It is therefore feasible that HMGA2 cooperates 
with several gene regulators at different steps of the EMT genetic programme not 
only in tumourigenesis (Heldin et al., 2009) but also in NCC EMTs”. So we never 
said we demonstrated that hmga2 is required at the EMT and migration stage, but 
only suggested it is feasible. 
We know, however, that is an important point and the main limitation of the paper, 
because, as already stated in the submitted version, we did not uncouple the early 
effect in the specification phase from a possible later, more direct, effect on EMT and 
migration. There are examples where this has been done. For instance LaBonne and 
Bronner-Fraser, 2000 and Aybar et al., 2003, have used an inducible dominant 
negative approach to knockdown Snail1 and Snail2 functions and tear apart early 
from late requirements; these reagents have worked very nicely, presumably because 
the corresponding non-inducible version hade a very strong antimorphic effect. Our 
Hmga2EnR construct could be in principle made into a GR inducible fusion form, to 
be activated at later stages. However, the Hmga2EngR has a much weaker effect 
compared to our MOs, and compared to the efficiency of the constructs used in those 
studies, both in terms of intensity of effects and in frequency of affected embryos. 
For this reason, we thought that results of similar experiments with an inducible, but 
leaky constructs, may not be sufficiently clear and interpretable and that we might 
need a more efficient antimorphic construct. For these reasons, given the evidence for 
a role of Hmga2 in orchestrating tumoral EMT (by directly acting on snail2 and twist 
promoters among others), we thought that the breast cancer cell model would be a 
better system where we could tackle, in the context of EMT, the effects of hmga2 
depletion on genes of the NCC network. Consistent with the results presented here, 
we have added a complete new paragraph to discuss thoroughly this limitation of our 
study (also in connection to previous studies) (see page 22). We make clear that we 
cannot conclude definitely about a direct role of hmga2 at the stage when EMT starts 
in NCCs, though, based on our tumor cell model and on previous evidence from other 
papers, we still suggest this is likely. We hope this discussion may be helpful to make 
clear and acceptable our point of view. 
 
 
2) The Referee also says that it is not clear what cell fates are lost in the neural crest 
region.  
RESPONSE: We do not completely agree: we show that developing cranial ganglia 
are erased (Fig. S3H), as detected by absent neuroD1 expression; and that skeletal 
derivatives of cranial NCC are heavily affected (almost the whole pharyngeal 
skeleton is disrupted or missing), in agreement with downregulation of sox9 positive 
scheletogenic crests (shown in Fig. 2). 
 
3) The Referee asks for a better characterization of the neural phenotype. Considering 
that hmga2 is widely expressed in the developing CNS, he/she asks for spinal cord 
and hindbrain markers, and for a characterization of the neural fate specificity of  
hmga2 knock down phenotype. 
RESPONSE: To better characterize these aspects, we have analysed hindbrain and 
spinal cord markers, as suggested by the Referee, as well as markers of neurogenesis. 
In addition to absence of effects on otx2 and nrp1 (already examined in the original 
version), we found that there is basically no alteration on the expression of positional 
neural markers such as en2, krox20 and hoxb9 within the midbrain and hindbrain 
region and spinal cord (interestingly, though, krox20 positive NCCs show reduction).  
As for any effect on neuronal commitment, analysis of neurog1, elr-c and tubb2b (N-
tubulin) shows reduction of all these markers (e.g. in primary neurons, trigeminal 
ganglion) a phenotype consistent with a role of hmga2 in neural cell state. This 
phenotype is interesting and certainly deserves further attention. However, we feel 
that a full analysis of this aspect goes beyond the focus of the present paper on NCCs. 
Therefore we will pursue these aspects in a separate work. 
All these results are displayed in two new Supplementary Figures (Fig. S4 e S5), 
described in Results and commented in the Discussion. 
 
 
Response to Reviewer 2 
 
A few minor points should be addressed:  
1- In Figure 1, stage 13 it seems that the whole lateral neural plate border is 
expressing hmga2, thus, it is better to change the label "NCC" to "NPB" and extend 
the area outlined in red to the rest of the neural plate border. 
RESPONSE: This has been done as suggested by the referee 
  
2- In figure 1, it would be nice to decrease the size of the letters, so that they do not 
hide parts of the embryos. 
RESPONSE: This has been done as suggested by the referee 
 
3- In figure S1, the decrease in Hmga2 protein levels does not seem "strong": could 
the authors perform a quantitation by densitometry to evaluate this diminished 
expression? 
RESPONSE: a densitometry has been performed and quantification results in Hmga2 
protein being abated to around half the amount (Fig. S1D). 
 
4- In Figure 2, the two first panels could be larger, and numbers and % put in the 
figure legend to gain space within the figure itself. 
RESPONSE: all numbers and % were removed in order to gain space for the pictures 
and moved into the legend of Fig. 2 
 
5- Figure 2, Twist rescue: the embryo on the picture shows a very anterior staining 
for lacZ, the authors should choose another embryo, with larger injected area 
encompassing all the side of the head.  
RESPONSE: the pictures were changed as suggested by the reviewer 
 
6- Figure 4: Since hmga2 expression is stronger at stage 25, could the authors add 
msx1 injection and MO-snail injection at stage 25, to make the phenotype more 
obvious. 
RESPONSE: this has been done; Fig. 4 was reformatted and results of the relative 
experiments were included in Supplementary Tables  
 
7- Figure 6: after pax3 injection, hmga2 seems reduced on the chosen picture, 
contrarily to what the counting on the table suggests: the authors should replace this 
picture. 
RESPONSE: the picture was replaced with that of another embryo as suggested by 
the referee. 
 
8- the fact that hmga1 is not present in frog should be mentioned in the introduction. 
RESPONSE: the sentence was removed from the Discussion and mention of hmga1 
absence in Xenopus genome was given in the Introduction. 
 
 
Response to Reviewer 3 
 
We are glad that the reviewer finds merits and considerable interest in our paper. 
 
The points he/she raises are essentially the same as Reviewer 1. In order to better 
characterize the neural phenotype and to exclude that hmga2 depletion in the CNS 
has generalized effect, but has more specific ones, we have perfomed additional 
experiments with other markers. We observed that patterning genes are not upset, 
while markers of neurogenesis were downregulated. We discuss these findings in the 
new version (page 20, 1st paragraph) and suggest that the results on neurogenesis 
markers will require further investigations in a separate piece of work. 
 
As for the point about how direct the requirement for hmga2 may be in subsequent 
behaviors of the neural crest, we agree with the referee that this may be a difficult 
issue to address in the Xenopus system due to the epistatic position of hmga2 with 
respect to the NC specifier genes (see also response to Referee 1). We are aware of 
this limitation and we tried to make this more explicit and to discuss this more deeply 
than in the previous version. We have extended the Discussion on this limitation of 
our work (page 22). We hope we have improved the conceptual connection between 
part 1 on embryos and part 2 on cells, both in the Results and in the Discussion. 
 
 
 
 
 
 
 
 
LIST OF MODIFICATIONS WITH RESPECT TO THE PREVIOUS MS (page 
number refer to the revised version) 
  
1) ABSTRACT, page 2: “towards the branchial pouches are also compromised”. also 
was added 
2) HIGHLIGHTS, page 3: “hmga2 knockdown early effects also impair subsequent 
NCC EMT and migration instead of “hmga2 knock-down impairs NCC EMT and 
migration” 
3) INTRODUCTION, page 6, last paragraph: the following sentence was added “In 
Xenopus only hmga2, but not hmga1, is present (Macrì et al., 2013); the frog 
therefore provides a unique opportunity to study hmga2 role during embryogenesis 
without any possible redundancy by hmga1.” 
4) MATERIALS AND METHODS, page 8, 1
st
 paragraph in Xenopus embryology: a 
simplification was made by mentioning that all the probes used in the study were 
previously referenced, instead of mentioning each of them one by one. Three new 
references were introduced, but of the previous ones were eliminated. 
5) RESULTS, page 12: 1st paragraph, 2nd line : “in the area of” was replaced with  
“in the neural plate border region encompassing” 
6) RESULTS, page 12,  1st paragraph, 3rd line  from end of paragraph: “(about 50% 
according to densitometry)” was added. 
7) RESULTS, page 13, after the 3rd paragraph: a completely new paragraph was 
inserted to describe the new results concerning positional neural markers and markers 
of neurogenesis. 
8) RESULTS, page 14, 3rd paragraph: the initial sentence of the paragraph “Because 
HMGA2 is involved in tumour EMT and snail2 and twist are key genes promoting 
EMT and normal cell migration in both NCCs and tumour progression (LaBonne and 
Bronner-Fraser, 2000; Soo et al., 2002; Thuault et al., 2006, 2008; Watanabe et al., 
2009; Wu et al., 2011; Tan et al., 2012; Guo et al., 2013; Morishita et al., 2013), we 
asked whether Hmga2 depletion impaired EMT and migration of NCCs during 
development.” was replaced with the following: “snail2 and twist are key genes in 
NCC specification that also promote EMT and normal cell migration both in NCCs 
and in tumour progression (LaBonne and Bronner-Fraser, 2000; Soo et al., 2002; 
Thuault et al., 2006, 2008; Watanabe et al., 2009; Wu et al., 2011; Tan et al., 2012; 
Guo et al., 2013; Morishita et al., 2013); because of the effects of Hmga2 depletion 
on these genes, we would expect that hmga2 knockdown would also impair EMT and 
migration of NCCs during development.” 
9) RESULTS, page 15, 8th line from the top: the sentence “Therefore, Hmga2 plays a 
cell-autonomous role in NCCs that is required for their EMT and migration” was 
modified into “Therefore, Hmga2 plays a cell-autonomous role in NCCs that is 
required for their subsequent EMT and migration.”  
10) RESULTS, page 15, in Hmga2 and the NCC gene network, last three lines of 
the page: additions were made to introduce the results of Msx1 injected embryos 
analyzed at tailbud stage. 
11) RESULTS, page 16, 3rd line: additions were made, to describe the results of 
MO-snail2 injection on hmga2 expression at tailbud stage. 
12) RESULTS, page 16, 3rd paragraph, 2nd line: the sentence “....but upstream of 
snail2 and twist in the NCC genetic network. “ was modified into “...but upstream of 
snail2 and twist in the initial phase of the NCC genetic network.” 
13) RESULTS, page 18, in Molecular analysis of Hmga2 function in a 
mammalian EMT model of breast cancer: The initial sentence “We then asked 
whether the hmga2-dependent molecular interactions observed in Xenopus NCCs 
could be validated in a mammalian cell model. Because HMGA2 is a crucial player 
in EMT and tumour progression, we chose the murine mammary epithelial NMuMG 
cells, a breast cancer model where EMT can be elicited by TGF-β with the 
determinant role of HMGA2 (Thuault et al., 2006, 2008).” was modified into 
“Because HMGA2 is a crucial player in EMT and tumour progression, we then asked 
whether the hmga2-dependent molecular interactions observed in Xenopus NCCs 
could be validated in a mammalian cell model for EMT. We chose the murine 
mammary epithelial NMuMG cells, a breast cancer model where EMT can be elicited 
by TGF-β with the determinant role of HMGA2 (Thuault et al., 2006, 2008).” 
14) DISCUSSION, page 20, 1
st
 paragraph: this paragraph has been rearranged as 
follows. After the first sentence, a sentence resuming the expression of hmga2 in 
NCCs: “Xenopus hmga2 is transcribed NCCs during their specification and in their 
EMT and migratory phase (Benini et al., 2006; Monzen et al., 2008; present work).” 
was moved here from below. The sentence concerning the absence of hmga1 in 
Xenopus, was cut away from here and moved in the Introduction (see point 3). In 
addition, a few sentences were introduced to describe the effects of MOs on neural 
patterning genes as well as on neurogenesis markers. These sentences make up a 
great part of the first paragraph (up to its end) in this new version. Minor 
modifications were also made. 
14) DISCUSSION, page 21, 2nd paragraph, 13
th
 line from the top: the part “We also 
show that hmga2 early expression at neurula stage depends on msx1, but not on 
snail2 function. These data altogether suggest that hmga2 acts downstream of msx1, 
but is required for the expression of snail2 and other NCS genes.” has been modified 
into “We also show that initial hmga2 early expression at neurula stage depends on 
msx1, but not on snail2 function. Our data altogether suggest that hmga2 acts 
downstream of msx1, but is required for the initial expression of snail2 and other 
NCS genes.” 
15) DISCUSSION, page 22, at the beginning of the page: a few sentences were added 
to discuss more deeply the issue of hmga2 requirement at a later stage than initial 
specification. 
16) DISCUSSION, page 22, last paragraph, end of the page: The sentence “To get 
more insights about the molecular connections among hmga2, EMT and the NCC 
genes that we examined in Xenopus embryos,” was added at the beginning of the 
phrase. A small modification was also made at the end of the page. 
17) DISCUSSION, page 23, at the end, a new paragraph was added to summarize the 
conclusions, clearly stating the overall significance of the paper. 
17) FIGURE LEGENDS, page 37 and following: legends to Figure 1, 2 and Figure 4 
were modified according to Referees’ indications and to accommodate the numbers 
and % previously shown in Fig. 2 and to accommodate description of the new Results 
presented in the MS. 
18) SUPPLEMENTARY MATERIALS AND METHODS, page 41, in Western blot 
analysis of proteins from Xenopus embryos: A part was added to describe the 
densitometry. 
19) LEGENDS TO SUPPLEMENTARY FIGURES, page 43 and following: In 
legend to Fig. S1, description of the densitometry on Western Blot; then two new 
legends were created for two new supplementary figures (Fig. S4 and S5) 
 
 
Other minor and not substantial modifications were made in the text in the various 
sections and are not detailed here. These concern Authors’ affiliation, references in 
the text to Figures that have been modified according to Referees’ request, 
modification of Tables to integrate data from the requested experiments, integration 
of references etc. 
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ABSTRACT 
 
HMGA proteins are small nuclear proteins that bind DNA by conserved AT-
hook motifs, modify chromatin architecture and assist in gene expression. Two 
HMGAs (HMGA1 and HMGA2), encoded by distinct genes, exist in mammals and 
are highly expressed during embryogenesis or reactivated in tumour progression. We 
here addressed the in vivo role of Xenopus hmga2 in the neural crest cells (NCCs). 
We show that hmga2 is required for normal NCC specification and development. 
hmga2 knockdown leads to severe disruption of major skeletal derivatives of anterior 
NCCs. We show that, within the NCC genetic network, hmga2 acts downstream of 
msx1, and is required for msx1, pax3 and snail2 activities, thus participating at 
different levels of the network. Because of hmga2 early effects in NCC specification, 
the subsequent epithelial-mesenchymal transition (EMT) and migration of NCCs 
towards the branchial pouches are also compromised. Strictly paralleling results on 
embryos, interfering with Hmga2 in a breast cancer cell model for EMT leads to 
molecular effects largely consistent with those observed on NCCs. These data 
indicate that Hmga2 is recruited in key molecular events that are shared by both 
NCCs and tumour cells. 
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HIGHLIGHTS 
 
1) hmga2 is required for neural crest cell (NCC) specification in Xenopus 
2) hmga2 acts at different levels of the NCC genetic hierarchy 
3) hmga2 knockdown early effects also impair subsequent NCC EMT and migration 
4) hmga2 morphant embryos show disrupted pharyngeal skeleton 
5) hmga2 molecular interactions with NCC genes are confirmed in an EMT cancer 
cell model 
 4 
KEY WORDS: 
HMGA2, neural crest, Xenopus, epithelial-mesenchymal transition, breast cancer 
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INTRODUCTION 
 
HMGA proteins (HMGA1 and HMGA2) are small proteins made of about 100 
aminoacid residues that bind AT-rich DNA regions through conserved AT-hook 
motifs and modify chromatin architecture (Reeves, 2001; Harrer et al., 2004; Sgarra 
et al., 2010). HMGA proteins can bend the DNA double helix to assist recruitment of 
other factors in enhanceosomes, thus participating in the transcriptional regulation of 
several genes (Thanos and Maniatis, 1992; Chau et al., 2000; Monzen et al., 2008). 
Hmga genes and proteins are mainly expressed during embryogenesis in 
undifferentiated and/or rapidly proliferating cells from all three germ layers 
(Chiappetta et al., 1996; Hinring-Folz et al., 1998), but are downregulated in 
differentiated adult tissues. Hmga2 inactivation in mice results in reduced body size 
(Zhou et al., 1995), while Hmga2 overexpression leads to gigantism (Battista et al., 
1999), suggesting its involvement in regulating proliferation. Moreover, Hmga2 
appears critical for skeletal muscle mass and fiber size (Li et al., 2012) as well as for 
neural and retinal stem cell state and renewal (Nishino et al., 2008; Parameswaran et 
al., 2014; Yu et al., 2015). On the other hand, mice homozygous or heterozygous for 
a null Hmga1 allele show cardiac hypertrophy and myelo-lymphoid malignancies 
(Fedele et al., 2006). Finally, most of double Hmga1/Hmga2 loss-of-function mutant 
mice die in utero; surviving pups display an extreme reduction in body size (Federico 
et al., 2014), suggesting involvement of both HMGAs in this aspect. 
While HMGA1 and HMGA2 are not expressed, or expressed at low levels, in 
adult tissues, they are upregulated in several types of tumours (Fedele et al., 2002, 
2006; Sgarra et al., 2004; Zaidi et al., 2006; Fedele and Fusco, 2010). Their 
association with tumourigenesis is reinforced by the observations that HMGA2 plays 
a key role in TGF-β induced epithelial-mesenchymal transitions (EMT), where it is 
activated and recruited by SMADs to turn on key genes like Snail1 and Twist (Fusco 
and Fedele, 2007; Thuault et al., 2006, 2008; Tan et al., 2012; Morishita et al., 2013), 
and that also HMGA1 is involved in EMT and migration (Pegoraro et al., 2013, 
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2015). 
 EMT is a key event in carcinoma invasion and metastasis (Yang and Weinberg, 
2008); however, regulated EMTs also occur during development, as in gastrulation or 
neural crest cell (NCC) migration. NCCs undergo EMT and successive migration to 
diverse regions of the embryo, giving rise to several derivatives, including skeletal 
and connective tissues of the head, peripheral neurons and glia, endocrine cells and 
melanophores (Le Douarin and Kalcheim, 1999). NCCs are induced by the combined 
action of BMP, FGF, NOTCH and WNT signals; these signals activate a first set of 
genes (the neural plate border, NPB, genes), like Pax3/7, Zic, Msx1/2 and Ap2, that 
identify the neural crest forming region at the boundary between the epidermis and 
the neural plate (Nikitina et al., 2009; Milet and Monsoro-Burq, 2012; Stuhlmiller 
and Garcia-Castro, 2012). These initial genes in turn activate the neural crest 
specifier (NCS) genes that, within this boundary, specify the NCC fate and promote 
EMT and migration; among them, the zinc finger genes Snail1 and Snail2 (also 
named Slug) and the bHLH factor gene Twist direct the delamination and migration 
of NCCs (Nikitina et al., 2009; Theveneau and Mayor, 2012), driving the change 
from a neuroepithelial to a mesenchymal morphology and leading to a shift in cell 
adhesive properties (Batlle et al., 2000; Yang et al., 2004; Peinado et al., 2004; 
Mayor and Theveneau, 2013). During EMT, matrix metallo-proteases (MMPs) are 
upregulated and act on the extracellular matrix to open a route for NCCs to migrate; 
several MMPs of the ADAM family have been described for Xenopus NCCs 
(Alfandari et al., 2001; Harrison et al., 2004), and their expression is, again, under the 
control of NCS genes, like Snail (Kuphal et al., 2005). Significantly, these molecular 
switches are also employed in tumour-linked EMTs (Kuriyama and Mayor, 2008; 
Yang and Weinberg, 2008; Thiery et al., 2009; Nieto, 2011). 
In Xenopus only hmga2, but not hmga1, is present (Macrì et al., 2013); the frog 
therefore provides a unique opportunity to study hmga2 role during embryogenesis 
without any possible redundancy by hmga1. Xenopus hmga2 is expressed in cells of 
the developing neural crest, and in other districts of the embryo, including the 
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developing heart and neural tube (Benini et al., 2006; Monzen et al., 2008). Because 
hmga2 regulates Snail and Twist genes in tumour EMT and is expressed in NCCs, we 
addressed its role in NCCs and its possible relationships to NPB and NCS genes. We 
show that knockdown of hmga2 function leads to downregulation of key genes, 
active in NCCs during their specification, EMT and migratory phases, thus impairing 
NCC migration and leading to severe disruption of the skeletal elements deriving 
from anterior NCCs. We show that hmga2 acts downstream of msx1 in the regulation 
of NCS genes; furthermore, Hmga2 may be required by Pax3 and Snail2 in the 
subsequent steps of the NCC genetic network. These data are extended and validated 
in a murine breast cancer cell model of EMT, suggesting Hmga2 as a key player both 
in NCCs and in tumour cells. 
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MATERIALS AND METHODS 
 
Xenopus embryology 
Xenopus embryos were obtained and staged as previously described (Newport 
and Kirschner, 1982; Nieuwkoop and Faber, 1994). In situ hybridizations were 
performed according to the protocol of Harland (1991), with modifications. All 
probes used in this study were referenced previously (Brivanlou and Harland, 1989; 
Hopwood et al., 1989; Papalopulu and Kintner, 1993; Mayor et al., 1995; Alfandari et 
al., 1997; Heller and Brandli, 1997; Misuzeki et al., 1998; Bang et al., 1999; Lupo et 
al., 2002; Spokony et al., 2002; Aoki et al., 2003; Luo et al., 2003; Monsoro-Burq et 
al., 2005; Benini et al., 2006; van Grunsven et al., 2006; Nichane et al., 2008). 
NCC transplantations and evalution of NCC ability of migration were performed 
as previously described (Reisoli et al., 2010; Cousin et al., 2012). Alcian Blue 
staining was carried out as reported (Pasqualetti et al., 2000), with minor 
modifications. 
 
Morpholinos, mRNA synthesis and embryo microinjections 
Xenopus laevis has two allelic isoforms of hmga2 (α and β), with slightly 
divergent 5’UTR sequences, but highly conserved coding regions (Benini et al., 
2006; Hock et al., 2006). To deplete all hmga2 variants, we used two non-
overlapping morpholino oligos (MO), one targeting a conserved region in the 5’UTR 
(MO2: 5’-GAGGGCAAACAAGGTCATAGGGCAC-3’) and the other the 
translation-initiation site (MO1: 5’-TTGGCGGGCTCCTTCCCTTGAGCTC-3’). 
2.5-10 ng of MOs were injected into the animal region of one of the dorsal 
blastomeres of 4-cell stage embryos, and led to similar effects. In parallel, a standard 
control oligo (STD MO: 5’-CCTCTTACCTCAGTTACAATTTATA-3’) and a 5 nt-
mismatched MO2 (5-mis MO: 5’-GAcGcCAAAgAAGcTCATAcGGCAC-3’, lower 
case letters indicate mismatched nucleotides) were used as controls; their injection at 
similar doses did not alter embryo development. MOs against Xenopus msx1 (MO-
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msx1) or snail2 (MO-snail2) were described in the literature (Monsoro-Burq et al., 
2005; Zhang et al., 2006). MOs were purchased from Gene Tools. 
Injected mRNAs were generated from pCS2-Xhmga2CR (containing only the 
Xenopus hmga2 coding region) or from snail2, msx1 or pax3 templates (Grammer et 
al., 2000; Suzuki et al., 1997; Monsoro-Burq et al., 2005) by in vitro transcription, 
using the Message mMachine kit (Ambion). 
GFP or β-galactosidase mRNAs were always coinjected as lineage tracers 
together with MOs or mRNAs. When GFP was used, embryos were scored by 
fluorescence for expected distribution of injected MO or mRNA and sorted according 
to left/right side of injection before being processed for WISH or other analyses. -
gal staining was performed as described (Hardcastle and Papalopulu, 2000). 
We tested different amounts of MO or mRNA in our microinjections to optimize 
their effects. For the experiments shown, unless different indications are given in the 
text or supplementary tables, injected amounts of MO or mRNA (either in 
combination or alone) were the following: MO1: 10 ng; STD: 10 ng; MO2: 2.5 ng; 5-
mis: 2.5 ng; MO-msx1: 15 ng; MO-snail2: 10 ng; for mRNAs: msx1: 100 pg; hmga2: 
200 pg; pax3: 100 pg; snail2: 500 pg; GFP: 600 pg; -gal: 400 pg. 
 
Cell cultures and reagents 
Mouse mammary epithelial NMuMG cells were grown in DMEM high glucose 
(Euroclone), supplemented with 2 mM L-glutamine, 10% Tet free fetal bovine serum 
(Euroclone), penicillin (100 U/ml, Euroclone) and streptomycin (100 µg/ml, 
Euroclone). 
NMuMG cells were stimulated with recombinant human TGF-β1 (Pepro-Tech, 
2.5-5 ng/mL) for 6 and 30 hours, while corresponding control cells (CTRL) were 
treated with vehicle (BSA 0.1% sterile water). 
The Hmga2 siRNA (siHMGA2: 5'-GCAGTGACCAGTTATTCTT-3') and 
control siRNA (siCTRL: 5’ACAGTCGCGTTTGCGACTG-3’) were designed with 
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Block It RNAI Designer tool (Invitrogen) (Hmga2 accession number NM_010441). 
 
Cell transfections 
NMuMG were seeded at 80.000 cells per well in 24-well plates in complete 
medium without antibiotics (penicillin/streptomycin). Cells were transiently 
transfected with Hmga2 siRNA or control siRNA using Lipofectamine® RNAiMAX 
reagent (Invitrogen). After two rounds of silencing every 24 hours, cells were 
stimulated with TGF-β, and corresponding control cells with BSA 0.1% in sterile 
water. After 2 hours of stimulation with TGF-β, cells were re-transfected with 
siRNAs for 16 hours.  
 
Quantitative real time RT-PCR and classic RT-PCR 
For quantitative real time RT-PCR (qRT-PCR), three biological triplicates for 
each group (siCTRL or siHMGA2 ± TGF-β) were prepared. Total RNA was 
extracted using TRIzol reagent (Invitrogen), subjected to DNase-I (Invitrogen) 
treatment and subsequently purified by phenol-chloroform extraction; mRNA was 
reverse-transcribed using Superscript III (Invitrogen). qRT-PCR was performed using 
IQ
™
 SYBR® Green Supermix (Bio-Rad). For relative quantification, the Gadph gene 
was used as internal standard and reference; all the primers (Table S1) were created 
using Primer3Plus software according to NCBI and Ensembl sequence databases. The 
CFX96 Real-Time PCR detection system (Bio-Rad) was used to perform quantitative 
PCR; all experiments were in biological triplicate and technical duplicate. 
For classic RT-PCR, diluted 1st strand cDNAs were amplified using specific 
primers and GreenTaq mix 2X (Promega). Amplification products were analysed on 
10% polyacrylamide TBE gel, and densitometric analysis was carried out using 
Quantity One 1-D analysis software (Bio-Rad), with endogenous Gapdh as internal 
control and normalizer. 
 
Statistical analysis 
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Data were analysed by a two-tailed Student's t-test and results were considered 
significant at a p-value < 0.05. The results are presented as the mean ± standard 
deviation (SD). 
For some microinjection experiments, data are reported as frequency of embryos 
among different phenotypic categories. In these cases, statistical analysis was 
performed using a chi-square test on absolute embryo number in each category; 
results were considered significant at a p-value < 0.05. 
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RESULTS 
 
Xenopus hmga2 knockdown impairs NCC development and migration 
During Xenopus development, hmga2 localized transcripts are first detected at 
stage 13, in the neural plate border region encompassing the presumptive anterior 
NCCs and in the pre-placodal plate (Fig. 1A); successively, hmga2 transcripts are 
clearly detected in the forming central nervous system (CNS), and in the developing 
streams of the NCCs (Fig. 1B-D; Benini et al., 2006; Monzen et al., 2008). To 
analyse hmga2 potential role in NCCs, we injected MO antisense oligonucleotides 
(MO1 and MO2, see Materials and Methods) to block its function. To test for their 
effectiveness, we first injected the MOs in both blastomeres of 2-cell stage embryos 
(2.5-10 ng each blastomere) and used a specific antibody (Rizzi et al., 2013) to detect 
the amount of Hmga2 protein in stage 13 injected and control embryos by Western 
blot; injection of either MO1 or MO2 led to strong downregulation (about 50% 
according to densitometry) of the Hmga2 protein compared to control uninjected 
embryos or to embryos injected with a 5-mismatched MO (5-mis) (Fig. S1A-D). 
In subsequent experiments, to target our MOs to the NCC region, embryos were 
injected unilaterally at the 4-cell stage in one of the dorso-animal blastomeres; though 
we mostly describe results obtained with MO2, also MO1 gave similar effects. In 
particular, injection of either MO resulted in a strong hypomorphism in the branchial 
region at tailbud stage (stage 28) (Fig. 2A), anticipating facial malformations 
observed at later stages on the injected side. Alcian blue cartilage staining, performed 
on stage 46-49 larvae, showed that Hmga2 depleted embryos failed to develop 
normal NCC craniofacial skeletal derivatives and otic capsules (Fig. 2B-E; Table S2). 
At variance, injection of the same amounts of a standard (STD) control MO or of 5-
mis MO did not affect skeletal phenotype (Fig. 2F,G; Table S2). 
To understand the molecular basis of these effects, we looked for possible 
alterations in the expression of genes involved in NCC induction, EMT and 
migration, as well as in early CNS and placodal development. In particular, we 
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analysed the effects of Hmga2 knockdown on the expression of the NCC markers 
twist, sox9, dlx2 and ap2 by whole mount in situ hybridization (WISH) at tailbud 
stage (stage 26-28). Severe downregulation or absence of expression of these genes 
was observed on the side injected with MO1 or MO2 (Fig. 2H; Table S3); no effect 
was observed upon injection of STD or 5-mis MOs (Fig. S2; Table S3). 
We then monitored whether a form of Xenopus hmga2 mRNA lacking the MO 
target sequence could rescue these effects. Coinjection of 5.2 ng MO2 and 6.25-12.5 
pg of hmga2 mRNA rescued normal twist expression in about 51-53% of injected 
embryos compared to 12-15% when MO2 was injected alone, while the frequency of 
embryos with decreased twist expression was reduced to 47-49% in coinjected 
embryos compared to 85-88% in MO2 injected embryos (Fig. 2I; Table S6A). 
Significantly, when grown up to tadpole stage, about 68% of similarly coinjected 
embryos showed a rescued normal skeletal phenotype, compared to the 35% of 
embryos displaying a normal skeleton when injected with MO2 alone (Fig. 2I; Table 
S6B). 
We then checked for possible alterations in the expression of the placodal and 
CNS molecular markers sox2, neuroD1 and pax2. At stage 18, sox2 (a marker of 
CNS and placodes) was strongly downregulated by MO2 in its placodal expression 
domain, while expression in the CNS was only weakly, if at all, affected (Fig. S3A-C, 
Table S3). Similarly, at tailbud stage, the signal for pax2 and neuroD1 in placode-
derived structures (otic vesicle and cranial ganglia, respectively) appeared strongly 
reduced, while expression in the CNS was not disturbed (Fig. S3D-H, Table S3). 
These same molecular markers were not affected after injection of 5-mis MO (Table 
S3). 
Furthermore, no substantial effect was produced by hmga2 knockdown on the 
expression of nrp1 (pan-neural marker), or of patterning genes such as otx2 (forebrain 
and midbrain), en-2 (midbrain/hindbrain boundary) or hoxb9 (spinal cord) (Fig. S3I-
K; Fig. S4A,B,C,G,H; Table S4); interestingly, krox20 (hindbrain) was unaffected in 
its neural tube domain in rhombomeres 3 and 5, but was reduced or contracted in its 
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NCC domain derived from rhombomere 5 (Fig. S4D-F; Table S4). Although we did 
not observe effects on these neural markers, neurog1 (neuronal progenitors), elr-c 
and tubb2b (primary neurons) were severely downregulated on the injected side, 
either in the trunk region or in the trigeminal ganglion anlage or in both these 
domains, consistent with the distribution of the injected MO (Fig. S5; Table S5). 
Injection of Xhmga2EnR mRNA, encoding for a dominant negative Hmga2 
fusion to Drosophila engrailed repressor (Monzen et al., 2008), reproduced (though 
to a lesser extent) the reduction of twist expression observed after MO treatments, 
thus confirming the effects of hmga2 knockdown on NCCs (Fig. S6A; Table S7). 
On the whole these data show clear effects of hmga2 knockdown on NCCs. 
The strong reduction in the expression of NCC key genes observed in morphant 
embryos is not due to cell death. To prove this, we performed a time-course analysis 
on MO2 injected embryos: we monitored the pattern of expression of snail2 (at 
earlier stages 13 and 18) and of twist (at tailbud stage 22 and 25), as well as the 
apoptotic pattern, on the injected and control sides of the embryos. Both at stage 13 
and at stage 18 no apoptotic foci could be detected while, as discussed above, at these 
stages snail2 expression was reduced on the injected side of embryos (Fig. S6B). At 
tailbud stage 22 or stage 25, twist expression on the injected side was strongly 
reduced or absent compared to control side, while cell death was comparable on both 
sides of MO treated embryos (Fig. S6B; Table S8). 
snail2 and twist are key genes in NCC specification that also promote EMT and 
normal cell migration both in NCCs and in tumour progression (LaBonne and 
Bronner-Fraser, 2000; Soo et al., 2002; Thuault et al., 2006, 2008; Watanabe et al., 
2009; Wu et al., 2011; Tan et al., 2012; Guo et al., 2013; Morishita et al., 2013); 
because of the effects of Hmga2 depletion on these genes, we would expect that 
hmga2 knockdown would also impair EMT and migration of NCCs during 
development. To test this, we performed NCC transplantation experiments. NCCs 
were excised from neurula stage 13 embryos that had been injected with MO1 (or 
MO2 or 5-mis) along with GFP mRNA as a tracer; these NCCs were used to replace 
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equivalent cells in stage 13 uninjected host embryos; embryos were then grown and 
monitored to follow NCC migration. A clear impairment of migration was detected 
for MO1+GFP and MO2+GFP injected NCCs compared to control 5-mis+GFP 
injected NCC (Fig. 3), and was quantified as described (Cousin et al., 2012). In a 
reciprocal assay, RFP injected NCCs were transplanted in MO2+GFP injected hosts; 
in this case, transplanted NCCs normally migrated to the pharyngeal region (Fig. 3). 
Therefore, Hmga2 plays a cell-autonomous role in NCCs that is required for their 
subsequent EMT and migration. Time-lapse videorecording of transplanted embryos 
documents impairment of migration in MO2 compared to 5-mis MO injected NCCs 
(Suppl. Files 1 and 2). Consistent with this, we found that the expression of adam13, 
encoding a metalloprotease involved in NCC migrating ability (Cousin et al., 2012), 
and of zeb2, a transcription factor gene that promotes EMT (van Grunsven et al., 
2007; Nieto, 2011) was downregulated by MO2 (Fig. S6C; Table S3). 
 
Hmga2 and the NCC gene network 
We next examined the position of hmga2 in the NCC gene regulatory 
programme. The NPB genes msx1 and pax3 are among the earliest regulators of the 
NCC gene network, with msx1 playing a key role upstream of pax3 (Monsoro-Burq 
et al., 2005; Nikitina et al., 2009). We downregulated or overexpressed msx1 to see 
how hmga2 was affected. Injection of 15 ng of anti-msx1 MO (MO-msx1) caused a 
clear downregulation of hmga2 at both neurula (stage 13 and 16) and tailbud (stage 
25) stages (Fig. 4A-D; Table S9), while resulting, as expected (Monsoro-Burq et al., 
2005), in dowregulation of pax3, snail2 and twist at neurula (Fig. 4Q-S; Table S9); no 
effect was produced by similar amounts of STD-MO (Fig. 4E-H; Table S9). 
Conversely, injection of 100 pg of msx1 mRNA produced, as expected (Monsoro-
Burq et al., 2005), an increase of pax3, snail2 and twist expression at neurula stage 
(Fig. 4T,U,V; Table S9) and resulted in an enlargement of hmga2 expression domain 
at neurula (Fig. 4I,J; Table S9) and in a more mature expression of hmga2 at tailbud 
stage (Fig. 4K,L; Table S9). In addition, while anti-snail2 MO injection (10 ng), as 
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expected, strongly downregulated twist, it did not substantially alter hmga2 
expression at stage 16 (Fig. 4M,N; Table S9); however, when MO-snail2 injected 
embryos were analysed at tailbud stage, they showed a reduced hmga2 expression 
(Fig. 4O,P; Table S9). This may not be surprising; given the crucial role of Snail2 in 
NCCs, it may reflect NCC disruption or fewer cells migrating after snail2 
knockdown. 
We then examined the effects of Hmga2 depletion and overexpression on early 
key regulators of NCCs. MO2 injection did not affect expression of the NPB genes 
msx1, pax3, hairy2 and ap2, but led to downregulation of the NCS genes snail2 and 
sox10, as detected at stage 13 (Fig. 5A; Table S10). Consistent with this, when 
analysed at stage 16, MO2-injected embryos showed reduction of the expression of 
the NCS genes snail2 and twist, while the NPB genes msx1 and pax3 were 
unaffected; no effect was produced by 5-mis MO (Fig. 5B; Table S10). On the other 
hand, injection of varying amounts (50 pg-2 ng) of hmga2 mRNA did not alter the 
expression of msx1, pax3, snail2 or twist but in a minority of embryos, and most of 
the embryos showed a normal expression of these genes (Fig. 5B; Table S10; and 
data not shown). Therefore, Hmga2 is not required for the expression of the early 
NPB genes msx1, pax3, hairy2 and ap2, but is crucial for the expression of the NCS 
snail2 and twist; in addition, it is not sufficient for upregulating msx1, pax3, snail2 
and twist. 
On the whole, these data suggest that hmga2 could be required downstream of 
msx1, but upstream of snail2 and twist in the initial phase of the NCC genetic 
network. We therefore asked whether Hmga2 downregulation could block the effect 
of msx1, pax3 or snail2 on downstream genes. 
We observed that while msx1 mRNA injection increased pax3, snail2 and twist 
expression, coinjection of MO2 suppressed msx1 effect on snail2 and twist (but not 
that on pax3) (Fig. 6A; Fig. S7A-C; Table S11). On the other hand, coinjection of 
hmga2 mRNA did not seem to potentiate the effect of msx1 on snail2 or twist 
expression (Fig. 6A; Fig. S7A-C; Table S11). 
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When pax3 mRNA (100 pg) was injected, both snail2 and twist (but not hmga2) 
were upregulated; pax3 effect on snail2 and twist was suppressed by coinjection of 
MO2; instead, coinjection of hmga2 mRNA did not enhance the effect of pax3 on 
these markers (Fig. 6B; Fig. S7D,E; Table 11). 
Finally, Hmga2 depletion by MO2 also suppressed the effect of snail2 mRNA, 
that normally leads to the expansion of twist (Fig. 6C); coinjection of hmga2 and 
snail2 did not enhance significantly the increase of twist expression compared to 
snail2 injection alone (Fig. 6C; Fig. S7F; Table 11). 
These results altogether suggest that Hmga2 is required at different steps by 
Msx1, Pax3 and Snail2 to act on the expression of genes that come next in the NCC 
gene network. 
Earlier results showed that some of the msx1 effects on the NCC network are 
mediated by pax3 (Monsoro-Burq et al., 2005). Our results show that the effects of 
msx1 on NCS genes require Hmga2, while those on pax3 do not; in fact, MO2 blocks 
msx1-induced expansion of snail2 and twist expression, but not that of pax3 (Fig. 
6A). Because pax3 in turn also requires Hmga2 for its effects on snail2 and twist, it 
may be possible that Msx1 action on these two genes requires both Pax3 and Hmga2; 
then, MO-msx1 effects should be rescued more efficiently if pax3 and hmga2 
mRNAs are co-injected together. In fact, the effects of 20 ng of MO-msx1 on snail2 
and twist are partially rescued by 100 pg of pax3 mRNA (Fig. 7; Fig. S8; Table S12); 
interestingly, however, hmga2 expression is not rescued by pax3 (Fig. 7; Table S12). 
On the other hand, hmga2 mRNA (50 pg) does not rescue snail2 and twist expression 
in MO-msx1 injected embryos (Fig. 7; Fig. S8; Table S12). However, when both 
pax3 and hmga2 mRNAs are coinjected, a more effective rescue of snail2 and twist 
expression is obtained in msx1 morphants (Fig. 7; Fig. S8; Table S12). 
These results altogether show that msx1 expression is independent of Hmga2; 
msx1 regulates both hmga2 and pax3, possibly in a reciprocally independent way, 
during the initial steps of NCC genetic specification (see also Monsoro-Burq et al., 
2005); pax3 and hmga2 then cooperate downstream of msx1 to promote expression of 
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the NCS genes snail2 and twist. The activation of these two genes by msx1 and pax3 
is Hmga2-dependent; in addition, the ability of snail2 to reinforce twist expression 
also requires Hmga2 function. Therefore, msx1, pax3 and snail2 all require Hmga2 
for full exploitation of their activities. 
 
Molecular analysis of Hmga2 function in a mammalian EMT model of breast 
cancer 
Because HMGA2 is a crucial player in EMT and tumour progression, we then 
asked whether the hmga2-dependent molecular interactions observed in Xenopus 
NCCs could be validated in a mammalian cell model for EMT. We chose the murine 
mammary epithelial NMuMG cells, a breast cancer model where EMT can be elicited 
by TGF-β with the determinant role of HMGA2 (Thuault et al., 2006, 2008). As 
expected, TGF-β treatment significantly increased the mRNA expression levels of 
Hmga2 and those of the major EMT markers, including the mesenchymal genes 
Fibronectin (Fn1), Snail2 and Zeb2, both at 6 and 30 hours; in addition, at 30 hours, 
the treatment reduced the mRNA expression levels of the epithelial gene E-cadherin 
(Fig. S9A; and Thuault et al., 2006). Differently from Hmga2, the expression of the 
highly related Hmga1 gene was not induced upon TGF-β stimulation at either mRNA 
or protein levels (Fig. S9A,B; Thuault et al., 2006). 
After confirming Hmga2 upregulation in this EMT cellular model, we analysed 
how the genes modulated by hmga2 in Xenopus laevis NCCs responded to TGF-β in 
NMuMG cells and how they were affected upon Hmga2 depletion.  
The expression of Sox9, Pax2, EphrinB2 and Ap2 upon TGF-β induction was 
then assessed by qRT-PCR; since the expression levels of Sox10, Msx1 and Adam12 
(the murine mammalian counterpart most similar to Xenopus adam13) were too low 
to be successfully analysed with qRT-PCR, these genes were studied by semi-
quantitative RT-PCR. We found that Sox9 (Fig. 8A) and Sox10 (Fig. 8B), that are 
part of the NCC genetic network (Nikitina et al., 2009), were upregulated in NMuMG 
cells after exposure to TGF-β. Compared to untreated cells, Sox9 mRNA levels were 
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increased both at 6 and especially at 30 hours after treatment (Fig. 8A); Sox 10 
mRNA was dramatically upregulated after 6 hours TGF-β treatment, whereas at 30 
hours its expression was no longer detectable (Fig. 8B). Sox2 mRNA was also 
analysed, but was not detectable in our conditions (not shown). 
In addition to Sox genes, Adam12 was upregulated after 30 hours of TGF-β 
treatment (Fig. 8B). The expression of Pax2, EphrinB2, Ap2 and Msx1 instead was 
not significantly influenced by TGF-β exposure (Fig. 8A,B). 
Therefore, several of the different genes investigated in Xenopus NCCs, were 
consistently regulated also in the NMuMG cellular model. To understand whether the 
regulation of these genes was Hmga2-dependent, we silenced Hmga2. A specific 
siRNA (siHMGA2), designed against a sequence of the 3'UTR of the murine Hmga2 
mRNA, was transfected in NMuMG cells induced with TGF-β and the expression of 
the genes was analysed. As expected, Fn1, Snail2 and Zeb2, that are modulated by 
HMGA2 following TGF-β induction (Thuault et al., 2006, Tan et al., 2012), were 
downregulated upon Hmga2 silencing (Fig. 9A). Sox9, instead, seemed unaffected 
(Fig. 9A).  Moreover, we found that, following Hmga2 silencing, Sox10 and Adam12 
mRNAs were downregulated in TGF-β stimulated cells (Fig. 9B), consistent with 
their downregulation in Xenopus NCCs by MO2. 
Finally, we asked whether the genes that were not induced by TGF-β could be 
modulated by Hmga2 in uninduced conditions. We found that, in absence of TGF-, 
Ap2, EphrinB2 and Msx1 gene expression was not influenced by Hmga2 silencing 
(Fig. S8A,B), while a significant downregulation of Pax2 expression was detected 
(Fig. S8A). 
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DISCUSSION 
 
This study addresses the function of the chromatin architectural factor Hmga2 in 
the specification of NCCs in Xenopus laevis. Xenopus hmga2 is transcribed in NCCs 
during their specification and in their EMT and migratory phase (Benini et al., 2006; 
Monzen et al., 2008; present work). HMGAs have been associated with EMT, a key 
event in tumor progression that employs several of the molecular players acting in the 
genetic network of NCCs (Thuault et al., 2006, 2008; Wu et al., 2011; Tan et al., 
2012; Mao et al., 2013; Guo et al., 2013; Morishita et al., 2013; Pegoraro et al., 
2013). However, HMGA role in NCCs has never been investigated. For a loss-of-
function approach, we injected MOs to knock down Xenopus hmga2 function and 
assessed the effects of its downregulation at the early stages of NCC specification 
(early/mid-neurula stage), during tailbud stages when EMT and migration occurs, and 
finally when the NCC derivatives of the pharyngeal skeleton are formed. We also 
examined the effects of hmga2 knockdown on some neural markers of early 
patterning and neurogenesis. While the patterning genes analysed were not affected, 
we found some interesting effects on markers of neurogenesis. These consisted in a 
clear downregulation of neurog1, elr-c and tubb2b, suggesting a loss of neuronal 
precursors and primary neurons; their expression in the forming trigeminal ganglion 
was very often reduced or absent, in line with the later effect on neuroD1 expression 
in cranial ganglia. Although we did not pursue this interesting aspect in this paper, 
these results may reflect hmga2 role in maintaining a pool of neural stem cells within 
the CNS (Nishino et al., 2008; Parameswaran et al., 2014). We mainly focused this 
paper on the role of hmga2 in NCCs.  
Knockdown of hmga2 function in presumptive cranial NCCs leads to heavy 
phenotypic effects, and in particular to the disruption of NCC skeletal derivatives. 
Also the otic capsule and some placodal derivatives are frequently found impaired or 
missing, consistent with hmga2 expression in these structures or their prospective 
fields. These effects are specific because: (a) MO1 and MO2, but not control MOs, 
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downregulate Hmga2 protein levels, as detected by an anti-Hmga2 antibody; (b) 
standard control or mismatched MOs do not produce similar phenotypes; (c) the MO 
effects are rescued by hmga2 mRNA. 
These morphological alterations are explained by the strong downregulation of 
key NCC regulatory genes, detected at neurula and tailbud stages. Moreover, we 
demonstrate that although hmga2 is not required for the initial activation of NPB 
border genes, like msx1, pax3 and ap2, it is necessary for the expression of NCS 
genes such as snail2 and sox10 at neurula stage, as well as for the expression of NCC 
markers like twist, dlx2 and sox9, analysed at late neurula/tailbud stage during the 
EMT and migratory phase. Interestingly, initial ap2 expression at stage 13 is 
unaffected by hmga2 depletion, while its later expression and maintenance at tailbud 
requires hmga2; this may underlie the reiterative involvement of ap2 in the NCC 
network (de Crozé et al., 2011). We also show that initial hmga2 early expression at 
neurula stage depends on msx1, but not on snail2 function. Our data altogether 
suggest that hmga2 acts downstream of msx1, but is required for the initial expression 
of snail2 and other NCS genes. In particular, we show that both hmga2 and pax3 are 
consistently modulated by msx1, upon its downregulation or upregulation. However, 
their expression may be mutually independent. In fact, on one side, pax3 expression 
is not affected by hmga2 downregulation or overexpression in wildtype embryos; in 
addition, hmga2 depletion does not prevent pax3 upregulation by msx1 
overexpression. On the other side, injection of pax3 mRNA in wild type or Msx1-
ablated embryos does not upregulate or restore hmga2 normal expression, 
respectively. Coinjection experiments show that, downstream of msx1, hmga2 
cooperates with pax3 for the regulation of snail2 and twist: together, they can 
efficiently rescue the effects of MO-msx1. Furthermore, we show that hmga2 
function is required for the abilities of pax3 (positive effect on snail2 and twist) and 
of snail2 (positive effect on twist). Therefore, hmga2 plays a role in successive steps 
of the NCC genetic network, as a crucial node for eliciting several genetic activities 
that act in NCC specification and drive the programme that triggers the EMT and 
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migration of NCCs. Consistent with this, the compromised migration of Hmga2-
depleted NCCs could result from disrupting the early specification step, though it 
does not exclude that hmga2 could also play a later role in triggering the 
EMT/migration phase. Such a dual role, for example, has been shown for Snail1/2, 
that, in addition to their early role in specification, are also required from stage 16-17 
for the migratory phase of NCC (LaBonne and Bronner-Fraser, 2000; Aybar et al., 
2003). While we showed that initial snail2 (and NCS gene) expression requires 
Hmga2, we do not know if also this later phase of snail2 (and other NCS gene) 
expression requires Hmga2 at stage 16-17 and therefore is directly relevant for NCC 
EMT. Future work with inducible dominant negative hmga2 constructs will be 
required to assess this point. 
Although we did not uncouple the hmga2 knockdown early effects on NCC 
specification from possible later effects on EMT/migration, the proposed sequential 
role of hmga2 in Xenopus NCCs is consistent with observations in EMT cell culture 
models (our present results on NMuMG cells and following discussion). In fact, 
HMGA2 interacts with, and is recruited by, Smad4 for the activation of the Snail1 
promoter (Thuault et al., 2006, 2008). Similarly, HMGA2 is also involved in the 
activation of Twist by direct binding to its regulatory region, and in the epigenetic 
downregulation of E-cadherin, a target of the repressive activity of SNAIL1 and 
SNAIL2 factors (Thuault et al., 2006; Tan et al., 2012, 2015). It is therefore feasible 
that HMGA2 cooperates with several gene regulators at different steps of the EMT 
genetic programme not only in tumourigenesis (Heldin et al., 2009) but also in NCC 
EMTs; this capacity may be due to HMGA2 wide protein-protein interactive abilities 
(Sgarra et al., 2010), that could make it a versatile partner for different factors 
recruited at sequential steps during the deployment of the programme. 
To get more insights about the molecular connections among hmga2, EMT and 
the NCC genes that we examined in Xenopus embryos, we extended our analysis to 
the murine breast cancer model of NMuMG cells, where EMT can be induced by 
TGF- treatment with the pivotal role of HMGA2. In this EMT model we checked 
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whether some of the NCC network genes responded to interference of Hmga2 
function in a way consistent with our results on Xenopus NCCs. We found that some, 
though not all, of these genes (Snail2, Twist, Zeb2, Adam12, Sox10) were 
downregulated when Hmga2 function was impaired; others, like Sox9, were not, in 
spite of their induction by TGF- treatment. Interestingly, the relevance of ADAM12 
and SOX10 genes in human breast cancer is emerging: the expression of ADAM12 is 
associated with breast tumor-initiating phenotype and contributes to breast tumour 
growth (Li et al., 2012; Albrechtsen et al., 2013; Li et al., 2013) and SOX10 is 
preferentially expressed in triple-negative and metaplastic breast carcinomas 
(Cimino-Mathews et al., 2013). Their regulation by TGF- and by HMGA2 
underlines once more the cross-talk between molecular pathways that play an 
important role in EMT, embryonic development and breast cancer stem cells (Takebe 
et al., 2011). 
Among the genes examined, Msx1 was not upregulated by TGF- suggesting 
that it  does not participate in the TGF--induced EMT of NMuMG cells; its absence 
of regulation by Hmga2, also in basal conditions, is consistent with its higher position 
in the NCC network, acting at an earlier step than the actual initiation of EMT. On 
the other hand, though not induced by TGF-, Pax2 is downregulated in NMuMG by 
siHMGA2 in basal conditions; this suggests some modulatory ability of Hmga2 on 
Pax2. 
hmga2 cooperation in the regulation of specific genes may depend on the 
cellular context; indeed, in Xenopus embryos, we found that knockdown of hmga2 
leads to pax2 downregulation in the otic vesicle, but not in the neural tube, where 
hmga2 is also expressed. Similarly, also sox2 is downregulated by hmga2 ablation in 
its placodal domain; interestingly, evidence for direct regulation of SOX2 by HMGA2 
protein was recently shown in some cancer cell models (Chiou et al., 2013; Chien et 
al., 2015). 
In conclusion, our results altogether show a pivotal role of hmga2 in Xenopus 
NCC specification. Some, though not all, of the regulatory interactions of hmga2 in 
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the NCC genetic network are confirmed in a murine breast cancer model of TGF-
induced EMT (resumed in Fig. 10). These results strongly suggest, though do not 
definitely prove, that hmga2 may be required for EMT also in NCCs, acting through 
key regulators (such as snail2, twist, zeb2) to which hmga2 appears to be epistatic in 
a similar way to that described in tumor EMT (Thuault et al., 2006, 2006; Tan et al., 
2012; Guo et al., 2013). 
Besides HMGA2, several chromatin remodelers (Xenopus Brg1, Ajuba LIM 
proteins Lim1 and Wtip, Chd7, Brd7 and Lmo4; chick JMJD2A, PHD12 and LMO4) 
are important players in NCC development; interestingly, loss-of-function of these 
genes affects NCC migration and causes severe cranial skeletal malformations and/or 
downregulation of early NCC genes (Langer et al., 2008; Bajpai et al., 2010; Strobl-
Mazzulla et al., 2010; Strobl-Mazzulla et al., 2012; Ochoa et al., 2012; Ferronha et 
al., 2013). Therefore, chromatin remodelers may be pivotal players in regulating 
NCC biology; in turn, NCCs may be a key model where to explore epigenetic aspects 
potentially relevant to cancer (Nieto, 2011; Hu et al., 2014). 
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FIGURE LEGENDS 
 
Fig. 1 – Xenopus hmga2 expression in developing NCCs as detected by WISH. 
(A) hmga2 mRNA is expressed in the prospective neural plate border (NPB, outlined 
in red) and in the prospective placodal plate (PPP, outlined in black) of stage 13 
Xenopus embryo (dorsal-anterior view). (B) hmga2 expression at stage 16 (anterior-
lateral view) is visible in prospective neuroectoderm and cranial NCCs (arrowhead). 
(C-D) hmga2 mRNA is detected in the anterior NCCs (arrowhead) at stage 20 
(frontal view) and 28 (lateral view), respectively. 
 
Fig. 2 – Phenotypic and molecular effects of HMGA2 depletion on Xenopus 
embryos. (A) Stage 28 morphant embryos (ventral view) show a clear reduction (red 
arrowhead)  of the pharygeal bulges (bracket) (cg, cement gland). (B) Schematics of 
normal NCC migration in Xenopus embryos; ma, hy, br, denote mandibular, hyoid, 
branchial streams, respectively. (C) Schematics of skeletal derivatives of NCCs at 
tadpole stage; m, q, c, cb denote Meckel’s, quadrate, ceratohyal, ceratobranchial 
cartilages, respectively. (D-G) Pharyngeal skeletal phenotypes obtained following 
unilateral injections of MOs, as indicated; frequencies of the displayed phenotypes 
(D,E, morphant phenotype; F,G, wild type aspect) were 83% (n=130) and 76% 
(n=122) for MO1 and MO2 injections respectively. Typical phenotypes obtained with 
anti-hmga2 MOs consist in disruption or absence of branchial arch skeletal 
derivatives (stained in blue and indicated by arrows) and/or missing otic capsule 
(dashed circle) on injected side (left side in figure). (H) Effects of MO1 and MO2 on 
several NCC molecular markers as detected by WISH; expression was reduced by 
MO1 and MO2, respectively, in 75% and 76% of embryos for twist (n=124 and 
n=223); in 86% and 93% of embryos for sox9 (n=86 and n=84); in 85% and 73% of 
embryos for ap2 (n=66 and n=52); in 65% and 70% of embryos for dlx2 (n=61 and 
n=47). (I) The effects of MO2 are rescued by coinjection of hmga2 mRNA, as shown 
by recovery of normal twist expression (in 52% of embryos, n=99) and morphology 
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(in 68% of embryos, n=187). Injected side was determined by GFP visualization (D-
G) and -gal staining (H,I). 
 
Fig. 3 – Hmga2 depletion impairs NCC migration in Xenopus embryos. Cranial 
NCCs from GFP or RFP labeled embryos were transplanted into host embryos (see 
scheme in the upper part of figure). While 5-mis MO-injected NCCs migrated 
normally, MO1- or MO2-injected NCCs failed to migrate properly in host embryos 
(left). When wild type RFP-labeled NCCs were transplanted in GFP-labeled, MO2-
injected host embryos, they migrated regularly in the Hmga2-depleted environment 
(right). Pictures were taken at stage 18, 25, 30. Per cent inhibition of migration is 
indicated for MO1- or MO2-injected embryos relative to controls. 
 
Fig. 4 - msx1 modulates hmga2 expression in Xenopus embryos. (A-P) Msx1 but 
not Snail2 is required for hmga2 expression in prospective NCCs; depletion of Msx1 
leads to reduction of hmga2 expression (arrowhead) at stage 13, 16, and 25 (A-D); 
standard MO has no effect on hmga2 expression (E-H); msx1 mRNA expands hmga2 
expression, as shown at stage 13 (I, arrowhead) or at stage 16 (J, lines compare 
medio-lateral extension of hmga2 expression domain between two sides of embryo), 
and results in stronger hmga2 expression at stage 25 (K,L); MO against snail2 
mRNA does not affect hmga2 (M), but downregulates twist (N) at stage 16, but has 
some effects on hmga2 expression at stage 25 (O,P). (Q-V) Effects of msx1 depletion 
or overexpression on stage 16 sibling embryos are shown on pax3 (Q,T), snail2 
(R,U), twist (S,V). In all these embryos, injected side (inj) was scored by GFP 
fluorescence, except for (C,D,G,H,K,L,O,P) where -gal was used as a tracer. 
 
Fig. 5 - Hmga2 is required for NCS, but not for NBP, gene expression. (A) 
Xenopus embryos injected unilaterally with MO2 show downregulation of snail2 and 
sox10, but not of msx1, pax3, ap2 or hairy2 at stage 13. (B) Effects of hmga2 
knockdown or overexpression in stage 16 embryos: MO2 causes downregulation of 
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snail2 and twist, but not of msx1 or pax3; a mismatched control MO (5-mis) has no 
effect; hmga2 mRNA injection does not vary expression of these same genes. 
Injected side (inj) was scored by -gal staining (A),or by GFP fluorescence (B). 
 
Fig. 6 – Hmga2 is required for Msx1, Pax3 and Snail2 effects in the Xenopus 
NCC genetic network. (A-C) Embryos were injected unilaterally with msx1, pax3, 
or snail2 mRNA (alone or in combination with MO2 or hmga2 mRNA, as indicated) 
and subsequently analysed at stage 16 by WISH for expression of hmga2, pax3, 
snail2 and twist, as indicated. GFP mRNA was coinjected to visualize injected side 
(inj) in all embryos. 
 
Fig. 7 - pax3 and hmga2 synergize to rescue the effects of msx1 knockdown in 
Xenopus. Embryos were injected unilaterally with the indicated combinations of 
MO-msx1, pax3 and hmga2 mRNAs and were subsequently analysed at stage 16 by 
WISH for expression of hmga2, snail2 and twist, as indicated. Arrowheads show 
reduction of hmga2 expression on the injected side. GFP mRNA was coinjected to 
visualize injected side (inj) in all embryos. 
 
Fig. 8 - TGF-β stimulation regulates the expression of a novel set of genes, 
involved in the NCC genetic network, in a mouse breast cancer cell model. (A) 
Expression levels of mRNA encoding Sox9, Pax2, EphrinB2 and Ap2 genes were 
measured by real time RT-PCR at 6 and 30 hours after TGF-β treatment (5 ng/mL) in 
NMuMG cells, with respect to control cells (- TGF-β) set at 1 as reference. The data 
are represented as the mean ± SD (n=3). (B) Left panel shows representative RT-PCR 
amplification products of Sox10, Adam12 and Msx1 genes in NMuMG cells 
stimulated with TGF-β (6 and 30 hours of treatment, lanes 2 and 4 respectively) and 
in control cells (lanes 1 and 3) loaded on 10% TBE-PAGE. RT-PCR was carried out 
on the same biological triplicate samples as in A. Right panel shows densitometric 
analyses of RT-PCR products (n=3) of Sox10, Adam12 and Msx1 genes, comparing 
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cells exposed to TGF-β treatment (+TGF-β) with respect to control cells (-TGF-β) set 
at 1 as reference both at 6 and 30 hours. Sox10 densitometric analysis was not 
reported at 30 hours (± TGF-β) because PCR products were not detectable at this 
time point (n.d. in the graph). In both (A) and (B) Gapdh is used as control and 
internal normalizer. 
 
Figure 9 - Hmga2 downregulation modulates several NCC genes in the TGF-β 
induced EMT of mouse breast cancer cell model. (A) Relative mRNA expression 
levels of Hmga2, Fibronectin (Fn1), Snail2, Zeb2 and Sox9 genes in NMuMG cells 
silenced for Hmga2 gene (si_HMGA2) with respect to cells transfected with control 
siRNA (si_CTRL), set at 1 as reference, in TGF-β exposed conditions (2.5 ng/mL, 16 
hours after TGF-β treatment). Expression was measured by real time RT-PCR 
analyses and normalized against control cells (si_CTRL). The data are represented as 
the mean ± SD (n=3). (B) Left panel: gene expression analyses of Sox10 and Adam12 
of NMuMG cells exposed to TGF-β and silenced (si-HMGA2) or not (si-CTRL) for 
the expression of Hmga2; a representative image of RT-PCR analyses on 10% TBE-
PAGE is shown. Right panel: densitometric analyses of RT-PCR products (n=3) of 
Sox10 and Adam12 genes comparing cells silenced for Hmga2 gene (si_HMGA2) 
with cells transfected with control siRNA (si_CTRL), set at 1 as reference. In both 
(A) and (B) Gapdh is used as control and internal normalizer. 
 
Figure 10 - Scheme of hmga2 action on the NCC and EMT-promoting genes 
analysed in this study. In the Xenopus embryo, NPB genes (blue boxes), responding 
to earlier inducing signals, initiate the NCC genetic network; msx1 has a key position 
in eliciting pax3 and hmga2 expression (blue arrows). pax3 action on snail2 and twist 
is shown by red arrows; pax3 and hmga2 cooperate in their modulation. hmga2 
modulates the expression of several genes of the NCC genetic network (black 
arrows); genes shown in green and red boxes respond to TGF-, but only for the first 
group modulation by hmga2 was confirmed in the NMuMG breast cancer cell model. 
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